LifeStance Health closes $280M secondary offering

What's the deal? LifeStance HealthDealroom has a profile for this one. Try Dealroom → has completed a $275 million secondary public offering, with law firm Ropes & GrayDealroom has a profile for this one. Try Dealroom → advising on the transaction, announced in September 2026.

What's the endgame? As a post-IPO secondary, the offering allows existing shareholders to sell stock rather than the company raising new capital. The deal carried a headline figure of $280 million.

The signal: Secondary offerings at this scale point to continued investor appetite for the mental health provider's stock, giving early backers a route to liquidity in public markets.

Read more: ropesgray.com

Image credit: EU-Ukraine cooperation